FRIDAY, MAY 17, 2024 8:13:38 AM
My Quest A/c
Online Trading
Employee Email
Equity
|
Derivatives
|
Currency
|
Mutual Fund
|
IPO
|
Financial Tools
|
e-Voting
Home
|
About Us
|
Product and Services
|
corporate consultancy
|
empowered investor
|
download
|
career
|
contact us
Mission
Vision
Board of Directors
Memberships
Why Quest
Commodity
Currency
Equity and Derivatives
Quest News
Equity
Derivatives
Commodities
MutualFund
IPO
Currency
Depository
SEARCH
Quotes
News
NAV
Daily Market Tracker
Gainers & Losers
Advances & Declines
Value & Volume Toppers
Live Indices
Index Movers
Buyers & Sellers
Bulk Deals
Block Deals
Sector Watch
Market Analysis
New Highs & Lows
52 Week Highs & Lows
Exchange Holidays
Index Constituents
Unusual Volume
Out & Under Performers
Historical Returns
Stock Screener
Company Profile
Detailed Quotes
Company Background
Board Of Directors
Balance Sheet
Profit & Loss
Quarterly Results
Financial Ratios
Share Price
Price Chart
Beta Analysis
Deliverable Volumes
Technical Chart
Corporate Actions
BSE Announcements
NSE Announcements
Board Meetings
Book Closure
Bonus Issues
Rights Issues
Delisted Shares
Market Turnover
Change Of Names
Split Of Face Value
Merger & Demerger
Other Markets
ADR Prices
GDR Prices
World Indices
FII Activities
DII Activities
Forex Details
News
Pre-Session
Mid-Session
End-Session
Quick Review
Hot Pursuit
Foreign Markets
Other Markets
Corporate News
Market Beat
Economy News
Currency News
Market Commentary
Mutual Fund News
Commodity News
Corporate Results
Business News
Balance Sheet
Markets > Corporate Information > Balance Sheet
Concord Biotech Ltd
Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value
(
R
)
NSE
Symbol
Div Yield
%
Market Cap
(
R
s
.Cr)
P/E
(TTM)
EPS
(TTM)
Face Value
(
R
)
543960
INE338H01029
129.4003289
CONCORDBIO
0.47
15,269.26
50.73
28.77
1
Particulars
Mar 2023
(
R
s
.Cr)
Mar 2022
(
R
s
.Cr)
Mar 2021
(
R
s
.Cr)
Mar 2020
(
R
s
.Cr)
Mar 2019
(
R
s
.Cr)
Mar 2018
(
R
s
.Cr)
SOURCES OF FUNDS :
Share Capital
10.46
9.51
9.51
9.51
9.51
9.51
Reserves Total
1281.52
1097.65
990.16
760.57
672.99
584.85
Equity Share Warrants
0.00
0.00
0.00
0.00
0.00
0.00
Equity Application Money
0.00
0.00
0.00
0.00
0.00
0.00
Total Shareholders Funds
1291.98
1107.16
999.67
770.08
682.50
594.36
Secured Loans
31.24
60.59
86.35
35.53
0.00
13.40
Unsecured Loans
0.31
1.91
2.93
16.53
9.22
8.81
Total Debt
31.55
62.50
89.28
52.06
9.22
22.21
Other Liabilities
2.30
1.87
2.10
1.59
1.19
1.01
Total Liabilities
1325.83
1171.53
1091.05
823.73
692.91
617.58
APPLICATION OF FUNDS :
Gross Block
792.80
719.94
644.29
310.15
280.91
220.92
Less : Accumulated Depreciation
199.81
146.97
98.08
70.55
51.21
32.24
Less:Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
592.99
572.97
546.21
239.60
229.70
188.68
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
172.70
74.16
17.95
141.40
18.99
2.70
Producing Properties
0.00
0.00
0.00
0.00
0.00
0.00
Investments
137.72
74.39
141.65
198.77
229.33
151.06
Current Assets, Loans & Advances
Inventories
212.31
195.12
153.61
111.23
91.72
71.45
Sundry Debtors
273.76
232.17
177.52
183.51
158.61
219.69
Cash and Bank Balance
43.45
88.93
60.82
2.59
3.82
2.32
Loans and Advances
61.25
42.97
74.22
43.37
16.42
14.39
Total Current Assets
590.77
559.19
466.16
340.69
270.56
307.85
Less : Current Liabilities and Provisions
Current Liabilities
128.91
119.21
73.68
99.64
44.85
49.79
Provisions
36.47
1.75
0.66
2.08
0.12
0.00
Total Current Liabilities & Provisions
165.39
120.96
74.34
101.72
44.98
49.79
Net Current Assets
425.39
438.23
391.82
238.98
225.59
258.06
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets
2.18
1.95
0.60
0.59
0.00
3.53
Deferred Tax Liability
25.62
22.92
18.05
15.72
25.41
21.42
Net Deferred Tax
-23.44
-20.97
-17.45
-15.13
-25.41
-17.89
Other Assets
20.48
32.74
10.87
20.11
14.70
34.96
Total Assets
1325.83
1171.52
1091.05
823.74
692.90
617.58
Contingent Liabilities
14.31
13.32
3.89
3.89
0.00
0.00